Madrigal Pharmaceuticals Is A Biopharmaceutical Company Based In West Conshohockenpennsylvaniadedicated To Developing Innovativetreatments For Metabolic Dysfunction Associated Steatohepatitismash With A Team Of Over 500 Employees Across Theu Sand Europemadrigal Has Established Itself As A Leader In Mash Clinical Developmentfocusing On Addressing Thesignificant Unmet Medical Needs Associated With This Serious Liver Diseasethecompany S Flagship Productrezdiffraa Resmetirom Is Thefirst Fda Approved Treatment For Noncirrhotic Mash With Moderateto Advanced Liver Fibrosisthis Oral Therapy Works As A Liver Directed Thyroid Hormonereceptor Betathr I Agonisteffectively Reducing Liver Fatinflammationand Fibrosismadrigal Is Actively Expanding Its Therapeutic Applications Through Ongoing Clinical Trialsdemonstrating Its Commitment To Advancing Treatment Options For Adults At High Risk Of Diseaseprogressionthecompany Emphasizes A Cultureof Innovation And Collaboration With Hepatology Experts To Validateits Treatment Approaches
No conferences found for this company.
| Company Name | Madrigal Pharmaceuticals Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
